Crohn’s treatment shows promise

Israeli biotech Redhill announced positive results of the Phase 3 trial for RB-104 in treating Crohn’s disease which affects 1.5 million people worldwide.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *